mdi Consultants, Inc. Internationally Recognized Consulting Company to the MEDICAL DEVICE/IVD/PHARMACEUTICAL INDUSTRIES

mdi Consultants Inc. has the expertise and can provide you exceptional professional aid in the following areas:


Assist in FDA regulatory strategies – Pre-Sub, 513(g) and 510(K)s

· US Agent Services and Official Correspondent for Foreign Companies

. FDA EUA and conversion to 510 (k)s, Drug registration for Disinfectants

· MDSAP (Medical Device Single Audit Program) – implementation and preparation

· 510(k)/PMA/ANDA/NDA/DMF/IDE Planning - Preparation and Submission

· FDA compliance  - Regulatory strategy development, Pre-Sub, clinical trial development/ management, cGMP compliance, ISO, CE Mark, On-site audits, validation (process, software and sterilization)

. Assisting with “Breakthrough” Designation and working with AI devices

. Assisting with FDA inspections – prior to and during the FDA inspection

· FDA Troubleshooting and CRISIS INTERVENTION - Response to 483 and Warning letters – FDA mitigation

· UDI & GUDID Compliance

mdi leverages a proven and tested methodology with seasoned
and experienced consultants.

With over 200 years of cumulative industry experience on staff, we have delivered the following results: Helped over 500 companies achieve FDA compliance and/or ISO certification with 100% success in first time ISO certification and CE mark for over 1000 products Successfully prepared and submitted over a 3500 510(k) applications.

CONTACT INFOMATION 

Main Office:
55 Northern Blvd,

Great Neck,

NY 11021


(Tel.) 516-482 9001

(Fax) 516-482-0186
Email:  info@mdiconsultants.com
Website:  www.mdiconsultants.com

Go to article: Home | Taming the Wild WestGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Apple RubberGo to article: facultyGo to article: CommentGo to article: Russian import of essential medical devices to continue, but in reduced volumesGo to article: AI technology impacts gynaecological ultrasound by detecting preterm birthGo to article: FDA warns of false results in genetic non-invasive prenatal testingGo to article: Solid State Supplies Company Insight Go to article: TS Quality & EngineeringGo to article: In DepthGo to article: Taming the Wild West: regulating digital health appsGo to article: Covid-19: Mental health app growth reveals unmet needsGo to article: Remote clinical trial monitoring uptake rises but validation questions swirlGo to article: Covid-19 spurred on the self-testing revolutionGo to article: Is FDA LDT surveillance set to improve as VALID Act heads to resolution?Go to article: WatlowGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DataGo to article: Where is trade most likely to be disrupted in the medical industry from the RussGo to article: How big is the gender pay gap in the medical industry in Britain and who are the worst offenders?Go to article: SartoriusGo to article: mdi ConsultantsGo to article: MikronGo to article: EventsGo to article: Next Issue